Andreas Hadjimichael Net Worth & Insider Trades

Andreas Hadjimichael Karyopharm Therapeutics Inc

As of March 4, 2019

What is Andreas Hadjimichael's Net Worth?

The current estimated net worth of Karyopharm Therapeutics Inc's Andreas Hadjimichael is estimated to be about $175.15M . Andreas Hadjimichael owns about 6,000,000 units of Karyopharm Therapeutics Inc common stock. In the last 6 years at Karyopharm Therapeutics Inc, Andreas Hadjimichael has sold an estimated value of $94.39M worth.

What is Andreas Hadjimichael's Past Insider Trading?

Andreas Hadjimichael's largest purchase order was 500,000 units , worth over $17.77M on July 25, 2014. Andreas Hadjimichael's largest sale order was 278,115 units , worth over $11.66M on December 1, 2014. In total, Andreas Hadjimichael has made about 44 transactions over 6 years of their time at Karyopharm Therapeutics Inc. Andreas Hadjimichael usually trades in August, with the busiest year in 2014. The most recent transaction was a sale order of 149,624 units , worth over $619.11K on March 4, 2019.

Chione Ltd, Marcin Czernik, Andreas Hadjimichael, George Hadjimichael, Wiaczeslaw Smolokowski

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Andreas Hadjimichael's' Mailing Address?

  • Mailing address is Simou Menardou 8, Ria Court 8 Office 101, 6015 Larnaca G4 00000 Cyprus

What are Karyopharm Therapeutics Inc's Past Insider Trades?

Karyopharm Therapeutics Inc's most recent insider trade came on March 7, 2023 by Richard Paulson who sold 3,506 units worth $11.08K . In the last 10 years, insiders at Karyopharm Therapeutics Inc have sold an estimated value of $148.12M and bought an estimated value of $33.44M worth of shares. Insider trading is most common in February, with the busiest year in 2018. The most active traders at the company are Sharon Shacham, Chief Scientific Officer,  Michael Kauffman, Director,  and Andreas Hadjimichael .

Karyopharm Therapeutics Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...